Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7789]

Eribulin receives European commission marketing authorisation approval for advanced breast cancer after only one prior chemotherapy

Eribulin receives European commission marketing authorisation approval for advanced breast cancer after only one...

HIV-infected people with early-stage cancers are up to four times more likely to go untreated for cancer

HIV-infected people with early-stage cancers are up to four times more likely to go untreated for cancer

Lung-MAP trial launches using genomic profiling and targeting in advanced squamous cell lung cancer

Lung-MAP trial launches using genomic profiling and targeting in advanced squamous cell lung cancer

Scientists engineer nanoparticles to prevent bone cancer

Scientists engineer nanoparticles to prevent bone cancer

New approach identifies cancer mutations as targets of effective melanoma immunotherapy

New approach identifies cancer mutations as targets of effective melanoma immunotherapy

ESMO GI: Cetuximab or bevacizumab with combi chemo equivalent in KRAS wile-type metastic colorectal cancer

ESMO GI: Cetuximab or bevacizumab with combi chemo equivalent in KRAS wile-type metastic colorectal cancer

$ESMO GI: Phase III trial shows improved survival with TAS-102 in metastatic colorectal cancer refractory to standard therapies$

ESMO GI: Phase III trial shows improved survival with TAS-102 in metastatic colorectal cancer refractory to...

Leukaemia gene provides clue to treating triple negative breast cancer

Leukaemia gene provides clue to treating triple negative breast cancer

Cell division discovery could optimise timing of chemotherapy and explain some cancers

Cell division discovery could optimise timing of chemotherapy and explain some cancers

Continued use of low-dose aspirin may lower pancreatic cancer risk

Continued use of low-dose aspirin may lower pancreatic cancer risk

More from ecancer